The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 25, 2018
Filed:
Feb. 15, 2017
Applicant:
Elcelyx Therapeutics, Inc., San Diego, CA (US);
Inventors:
Alain D. Baron, San Diego, CA (US);
Mark S. Fineman, San Diego, CA (US);
Nigel R. A. Beeley, Solana Beach, CA (US);
Assignee:
ELCELYX THERAPEUTICS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/155 (2006.01); A61K 45/06 (2006.01); A61K 31/366 (2006.01); A61K 31/40 (2006.01); A61K 31/616 (2006.01); A61K 9/28 (2006.01); A61K 31/341 (2006.01); A61K 31/343 (2006.01); A61K 31/36 (2006.01); A61K 31/4196 (2006.01); A61K 31/53 (2006.01); A61K 31/55 (2006.01); C07C 279/26 (2006.01); C07D 317/58 (2006.01); C07D 401/04 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 249/14 (2006.01); C07D 251/10 (2006.01); C07D 251/18 (2006.01); C07D 255/02 (2006.01); C07D 207/06 (2006.01); C07D 207/34 (2006.01); C07D 211/14 (2006.01); C07D 307/52 (2006.01); C07D 307/66 (2006.01); A61K 9/00 (2006.01); A61K 31/41 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/0053 (2013.01); A61K 9/28 (2013.01); A61K 9/2846 (2013.01); A61K 31/341 (2013.01); A61K 31/343 (2013.01); A61K 31/36 (2013.01); A61K 31/366 (2013.01); A61K 31/40 (2013.01); A61K 31/41 (2013.01); A61K 31/4196 (2013.01); A61K 31/53 (2013.01); A61K 31/55 (2013.01); A61K 31/616 (2013.01); A61K 45/06 (2013.01); C07C 279/26 (2013.01); C07D 207/06 (2013.01); C07D 207/34 (2013.01); C07D 211/14 (2013.01); C07D 249/14 (2013.01); C07D 251/10 (2013.01); C07D 251/18 (2013.01); C07D 255/02 (2013.01); C07D 307/52 (2013.01); C07D 307/66 (2013.01); C07D 317/58 (2013.01); C07D 401/04 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01);
Abstract
Compositions and methods comprising at least one biguanide compound and at least one statin combined with at least one additional active agent in fixed dose combinations are provided for reducing cardiometabolic risk, and for the treatment of cardiovascular disease, wherein the biguanide compound is formulated for delayed release.